RxDoctor Payments Data

William Hammons, MD

Family Medicine · Bellevue, KYNPI 1457399024

Payments from drug & device makers

$7,816in general payments, 2019–2025

Across 497 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$811
  • GSK$739
  • Novo Nordisk$490
  • Boehringer Ingelheim$391
  • Pfizer$319
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$7,803100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,816 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$49,983
Medicare patients
205
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$52,868
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$40,923
OzempicSemaglutide25$34,049
JardianceEmpagliflozin19$24,257
Janumet XrSitagliptin Phos/Metformin Hcl12$19,432
JanuviaSitagliptin Phosphate12$17,506
MounjaroTirzepatide13$13,541
JanumetSitagliptin Phos/Metformin Hcl13$10,476
SymbicortBudesonide/Formoterol Fumarate19$8,040
Breo ElliptaFluticasone/Vilanterol16$6,382
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$6,171
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$4,527
Albuterol Sulfate HfaAlbuterol Sulfate93$3,054
Levothyroxine Sodium258$2,645
Atorvastatin Calcium342$2,599

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$319$52,86856 claims
MerckJanumet Xr, Januvia, Janumet$188$47,41537 claims
GSKTrelegy Ellipta, Breo Ellipta$739$47,30566 claims
Novo NordiskOzempic$490$34,04925 claims
Boehringer IngelheimJardiance$391$24,25719 claims
Lilly USA, LLCMounjaro$811$13,54113 claims
AstraZenecaSymbicort$184$8,04019 claims
AbbVieSynthroid$1,914$73514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Bellevue

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →